ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
61,655.35
4.29%
S&P 500
5,126.36
1.23%
Dow Jones
38,672.89
1.17%
US Dollar vs Yen
152.90
-0.10%
Brent Oil
83.09
-0.65%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Collegium Pharmaceutical Inc (COLL)

  7. Collegium Pharmaceutical Inc (COLL) ニュース

COLL Collegium Pharmaceutical Inc

37.59
0.08 (0.21%)
最終更新日： 01:55:59
15分遅延
名称 銘柄コード 市場 種別
Collegium Pharmaceutical Inc COLL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.08 0.21% 37.59 01:55:59
始値 安値 高値 終値 前日終値
37.80 37.48 38.32 37.51
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2921:00GLOBECollegium Announces Authorized Generic Agreement with Hikma..
2024/4/2521:00GLOBECollegium to Report First Quarter 2024 Financial Results on..
2024/4/1121:00GLOBECollegium Pharmaceutical, Inc. Announces Redemption of..
2024/4/0321:00GLOBECollegium to Participate in 23rd Annual Needham Virtual..
2024/3/0506:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:24EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2706:39EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2306:09GLOBECollegium Reports Record Fourth Quarter and Full-Year 2023..
2024/2/2306:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/2306:01EDGAR2Form 8-K - Current report
2024/2/1506:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1502:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0822:00GLOBECollegium to Report Fourth Quarter and Full-Year 2023..
2024/1/1906:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1706:20EDGAR2Form 144 - Report of proposed sale of securities
2024/1/0322:03EDGAR2Form 8-K - Current report
2024/1/0322:00GLOBECollegium Provides 2024 Financial Guidance
2023/12/2306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2206:15EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2107:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2106:28EDGAR2Form 144 - Report of proposed sale of securities
2023/12/2006:13EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1906:11EDGAR2Form 144 - Report of proposed sale of securities
2023/11/3006:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2807:00EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2722:00GLOBEAppeals Court Upholds PTAB’s Finding of Invalidity of..
2023/11/0922:05EDGAR2Form 8-K - Current report
2023/11/0922:00GLOBECollegium Announces $25 Million Accelerated Share Repurchase..
2023/11/0822:00GLOBECollegium to Participate in Upcoming Investor Conferences
2023/11/0806:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0806:01EDGAR2Form 8-K - Current report
2023/11/0806:01GLOBECollegium Reports Third Quarter 2023 Financial Results
2023/10/2421:00GLOBECollegium to Report Third Quarter 2023 Financial Results on..
2023/8/2821:00GLOBECollegium Announces 10 Poster Presentations at PAINWeek..
2023/8/2421:05EDGAR2Form 8-K - Current report
2023/8/2421:00GLOBECollegium Announces Extension of Nucynta Regulatory..
2023/8/1105:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/8/0720:40EDGAR2Form 8-K - Current report
2023/8/0720:30GLOBECollegium Announces $50 Million Accelerated Share Repurchase..
2023/8/0405:03EDGAR2Form 8-K - Current report
2023/8/0405:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0405:01GLOBECollegium Reports Record 1H’23 Net Revenue of $280.3..
2023/7/2021:00GLOBECollegium to Report Second Quarter 2023 Financial Results on..
2023/6/2905:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/6/0121:00GLOBECollegium to Participate in Jefferies Healthcare Conference
2023/5/0505:01GLOBECollegium Reports First Quarter 2023 Financial Results

最近閲覧した銘柄

NASDAQ
COLL
Collegium Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有